Measles & Rubella Weekly Monitoring Report: January 22 to January 28, 2017 (week 4)

Figure 1 - Text Description

Figure 1: Number of cases measles (n=0) and rubella (n=0), by week of rash onset, as reported to the Canadian Measles/ Rubella Surveillance System (CMRSS) and Measles and Rubella Surveillance system (MARS), for the period ending January 28, 2017.

Epidemiological Week of Rash Onset, 2017	Number of confirmed measles cases reported	Number of confirmed rubella cases reported
1	0	0
2	0	0
3	0	0
4	0	0
5	0	0
6	0	0
7	0	0
8	0	0
9	0	0
10	0	0
11	0	0
12	0	0
13	0	0
14	0	0
15	0	0
16	0	0
17	0	0
18	0	0
19	0	0
20	0	0
21	0	0
22	0	0
23	0	0
24	0	0
25	0	0
26	0	0
27	0	0
28	0	0
29	0	0
30	0	0
31	0	0
32	0	0
33	0	0
34	0	0
35	0	0
36	0	0
37	0	0
38	0	0
39	0	0
40	0	0
41	0	0
42	0	0
43	0	0
44	0	0
45	0	0
46	0	0
47	0	0
48	0	0
49	0	0
50	0	0
51	0	0
52	0	0
Missing Rash Onset	0	0
Cases (year-to-date)	0	0

Geographic Distribution

There are currently no reported active^{Figure 2 - Footnote *} cases of measles or rubella in Canada (Figure 2).

Maps from previous weeks, including any retrospective updates, are available online in the Measles and rubella weekly surveillance maps feature.

Figure 2 - Footnote *

Active cases or outbreaks are those in which the onset date of the most recent case/outbreak-associated case falls within 32 days of the issue date of this report^Footnote 2.

Return to first Figure 2 - Footnote * referrer

Figure 2 - Text Description

Figure 2: Distribution of active^{Figure 2 Table - Footnote *} confirmed measles cases by health region

Health Region	Measles Cases	Rubella Cases
Eastern Regional Integrated Health Authority	0	0
Central Regional Integrated Health Authority	0	0
Western Regional Integrated Health Authority	0	0
Labrador-Grenfell Regional Integrated Health Authority	0	0
Prince Edward Island	0	0
South Shore District Health Authority	0	0
South West Nova District Health Authority	0	0
Annapolis Valley District Health Authority	0	0
Colchester East Hants Health Authority	0	0
Cumberland Health Authority	0	0
Pictou County Health Authority	0	0
Guysborough Antigonish Strait Health Authority	0	0
Cape Breton District Health Authority	0	0
Capital District Health Authority	0	0
Zone 1 (NB)	0	0
Zone 2 (NB)	0	0
Zone 3 (NB)	0	0
Zone 4 (NB)	0	0
Zone 5 (NB)	0	0
Zone 6 (NB)	0	0
Zone 7 (NB)	0	0
Québec et Chaudières-Appalaches	0	0
Centre-du-Québec	0	0
Montréal et Laval	0	0
Ouest-du-Québec	0	0
Montérégie	0	0
Nord-Est	0	0
Ontario Central East	0	0
Ontario Central West	0	0
Ontario Eastern	0	0
Ontario North East	0	0
Ontario North West	0	0
Ontario South West	0	0
City of Toronto Health Unit	0	0
Winnipeg Regional Health Authority	0	0
Prairie Mountain Health	0	0
Interlake-Eastern Regional Health Authority	0	0
Northern Regional Health Authority	0	0
Southern Health	0	0
Saskatchewan South	0	0
Saskatchewan Central	0	0
Saskatchewan North	0	0
South Zone	0	0
Calgary Zone	0	0
Central Zone	0	0
Edmonton Zone	0	0
North Zone	0	0
British Columbia Interior	0	0
British Columbia Fraser	0	0
British Columbia Vancouver Coastal	0	0
British Columbia Vancouver Island	0	0
British Columbia Northern	0	0
Yukon	0	0
Northwest Territories	0	0
Nunavut	0	0
Figure 2 Table - Footnote * Active cases or outbreaks are those in which the onset date of the most recent case/outbreak-associated case falls within 32 days of the issue date of this reportFootnote 2. Return to Figure 2 Table - Footnote * referrer

Laboratory Summary

Measles

To date in 2017, no measles cases have been genotyped (Figure 3).

Figure 3 - Footnote †

Epidemiological weeks for laboratory specimens are assigned in accordance with WHO guidelines (WHO.WER.2012;9 (87):73) with week 1 beginning on the first Monday of the year.

Return to Figure 3 - Footnote † referrer

Figure 3 - Footnote *

Genotype B3 sequences identical to sequence variant / named strain MVi/Harare.ZWE/38.09 (GenBank accession number JF973033)

Return to Figure 3 - Footnote * referrer

Figure 3 - Text Description

Figure 3: Distribution of measles genotypes detected in 2017 (n=0) by week^{Figure 3 Table - Footnote †} of rash onset (if available, n=0) or specimen collection (n=0). Measles cases without specimens available for genotyping are not reflected (n=0).

Epi week	B3	B3 - Harare	D4	D8	D8 - Taunton	D9	H1	Total
1	0	0	0	0	0	0	0	0
2	0	0	0	0	0	0	0	0
3	0	0	0	0	0	0	0	0
4	0	0	0	0	0	0	0	0
5	0	0	0	0	0	0	0	0
6	0	0	0	0	0	0	0	0
7	0	0	0	0	0	0	0	0
8	0	0	0	0	0	0	0	0
9	0	0	0	0	0	0	0	0
10	0	0	0	0	0	0	0	0
11	0	0	0	0	0	0	0	0
12	0	0	0	0	0	0	0	0
13	0	0	0	0	0	0	0	0
14	0	0	0	0	0	0	0	0
15	0	0	0	0	0	0	0	0
16	0	0	0	0	0	0	0	0
17	0	0	0	0	0	0	0	0
18	0	0	0	0	0	0	0	0
19	0	0	0	0	0	0	0	0
20	0	0	0	0	0	0	0	0
21	0	0	0	0	0	0	0	0
22	0	0	0	0	0	0	0	0
23	0	0	0	0	0	0	0	0
24	0	0	0	0	0	0	0	0
25	0	0	0	0	0	0	0	0
26	0	0	0	0	0	0	0	0
27	0	0	0	0	0	0	0	0
28	0	0	0	0	0	0	0	0
29	0	0	0	0	0	0	0	0
30	0	0	0	0	0	0	0	0
31	0	0	0	0	0	0	0	0
32	0	0	0	0	0	0	0	0
33	0	0	0	0	0	0	0	0
34	0	0	0	0	0	0	0	0
35	0	0	0	0	0	0	0	0
36	0	0	0	0	0	0	0	0
37	0	0	0	0	0	0	0	0
38	0	0	0	0	0	0	0	0
39	0	0	0	0	0	0	0	0
40	0	0	0	0	0	0	0	0
41	0	0	0	0	0	0	0	0
42	0	0	0	0	0	0	0	0
43	0	0	0	0	0	0	0	0
44	0	0	0	0	0	0	0	0
45	0	0	0	0	0	0	0	0
46	0	0	0	0	0	0	0	0
47	0	0	0	0	0	0	0	0
48	0	0	0	0	0	0	0	0
49	0	0	0	0	0	0	0	0
50	0	0	0	0	0	0	0	0
51	0	0	0	0	0	0	0	0
52	0	0	0	0	0	0	0	0
Total	0	0	0	0	0	0	0	0
Figure 3 Table - Footnote † Epidemiological weeks for laboratory specimens are assigned in accordance with WHO guidelines (WHO.WER.2012;9(87):73) with week 1 beginning on the first Monday of the year. Return to Figure 3 Table - Footnote † referrer Figure 3 Table - Footnote * Genotype B3 sequences identical to sequence variant / named strain MVi/Harare.ZWE/38.09 (GenBank accession number JF973033) Return to Figure 3 Table - Footnote * referrer

The current global distribution of measles genotypes can be found on the WHO Measles Surveillance website.

For information regarding the interpretation and use of measles genotyping (including a discussion of genotypes and sequence variants), refer to Hiebert J and Severini A. Canada Communicable Disease Report. 2014; 40-12: 257- 260.

Rubella

To date in 2017, no rubella cases have been genotyped.

Footnotes